Nasal Spray Oxymetazoline HCl Recalled Due to Contaminated Excipient
Perrigo Company PLC is recalling Nasal Maximum Strength Nasal Spray (Oxymetazoline HCl 0.05%) due to contamination from a recalled excipient used during manufacturing. Approximately 2,302 bottles were distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this as a Class II recall. The source text does not report any illnesses, injuries, or deaths, and the hazard is related to a manufacturing deviation (contaminated excipient) without explicit statement of the nature or severity of potential harm. Per the rubric, Class II recalls without reported hospitalization typically fall to Moderate (score 2).
Plain-English summary
Perrigo Company PLC is recalling Nasal Maximum Strength Nasal Spray containing Oxymetazoline Hydrochloride 0.05% (1 FL Oz / 30 mL bottles, NDC 41250-989-10). The recall was initiated because the products were manufactured using a contaminated excipient that was itself recalled by the excipient supplier.
The affected batch is 1BK0716 with an expiration date of 12/31/2022. Approximately 2,302 bottles were distributed nationwide in the USA and were distributed by Meijer Distribution, Inc., Grand Rapids, MI.
The FDA has classified this as a Class II recall. Consumers who have purchased this product should stop use and consult their healthcare provider if they have any concerns about their health. Consumers with questions may contact Perrigo Company PLC or their pharmacy.
The recalled product
- Product
- NASAL (OXYMETAZOLINE HYDROCHLORIDE)
- Brand
- NASAL
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Nasal Decongestant / OTC
- Hazard
- contamination
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch: 1BK0716
- Exp 12/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NASAL
- ModerateNasal Decongestant Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateNasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateOxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModeratePerrigo Nasal Oxymetazoline Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same category
- ModerateTopCare Earwax Removal Kit Recalled for Subpotent Drug Content
FDA (Drugs) · 2026-07-22
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22